Andrew Walsh is a managing director at First Analysis, investing in healthcare software and supporting portfolio companies. He has over 20 years of healthcare experience, previously at Ciox Health and other firms, and founded a population health company sold to Guidewell in 2017.
What Andrew can write
First Analysis writes $3M to $10M checks, larger than 93% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: First Analysis.Career
- Ciox Health · senior leadership team
- First Analysis · Managing DirectorNow
- UnitedHealth Group
- Optum
- Davita
- Ciox Health
Companies founded
Investments named in public bios
Focus
Education
Also at First Analysis
Partners like Andrew
At firms with a similar stage, sector and check size.
Alert me when First Analysis is active
One email when Andrew's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Andrew Walsh?
Andrew Walsh is a managing director at First Analysis, investing in healthcare software and supporting portfolio companies. He has over 20 years of healthcare experience, previously at Ciox Health and other firms, and founded a population health company sold to Guidewell in 2017.
How much does Andrew Walsh invest?
Andrew Walsh invests through First Analysis, which writes checks of $3M to $10M at series a, series b.
How do I pitch Andrew Walsh?
A warm intro from a founder First Analysis backed works best. A short LinkedIn note with one line on traction is the next best route.
What did Andrew Walsh do before First Analysis?
senior leadership team at Ciox Health; UnitedHealth Group; Optum; Davita; Ciox Health.
Last updated 2026-10-15. Is this you? Ask for a correction.